{"id":67698,"date":"2026-06-08T22:03:06","date_gmt":"2026-06-08T14:03:06","guid":{"rendered":"https:\/\/flcube.com\/?p=67698"},"modified":"2026-06-08T22:03:08","modified_gmt":"2026-06-08T14:03:08","slug":"sino-medical-sciences-secures-colombian-approval-for-ht-supreme-drug-eluting-stent-advanced-dual-polymer-technology-expands-latin-american-presence","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=67698","title":{"rendered":"Sino Medical Sciences Secures Colombian Approval for HT Supreme Drug-Eluting Stent \u2013 Advanced Dual-Polymer Technology Expands Latin American Presence"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>Sino Medical Sciences Technology Inc.<\/strong> (<a href=\"https:\/\/www.google.com\/finance\/quote\/688108:SHA\">SHA: 688108<\/a>) announced it has received <strong>marketing approval<\/strong> from Colombia&#8217;s <strong>Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA)<\/strong> for its <strong>HT Supreme drug-eluting stent system<\/strong>. The approval enables commercial use in symptomatic heart disease patients with primary coronary artery lesions, marking a significant expansion of the Chinese medical device manufacturer&#8217;s presence in the Latin American cardiovascular market.<\/p>\n\n\n\n<h2 id=\"h-regulatory-approval-amp-indication-details\" class=\"wp-block-heading\">Regulatory Approval &amp; Indication Details<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Parameter<\/th><th>Specification<\/th><\/tr><\/thead><tbody><tr><td><strong>Regulatory Authority<\/strong><\/td><td>INVIMA (Colombia)<\/td><\/tr><tr><td><strong>Approved Indication<\/strong><\/td><td>Symptomatic heart disease due to primary coronary artery lesions<\/td><\/tr><tr><td><strong>Lesion Length<\/strong><\/td><td>\u2264 40 millimeters<\/td><\/tr><tr><td><strong>Reference Vessel Diameter<\/strong><\/td><td>2.25-5.00 millimeters<\/td><\/tr><tr><td><strong>Primary Benefit<\/strong><\/td><td>Improvement of coronary artery lumen diameter<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 id=\"h-product-technology-amp-innovation\" class=\"wp-block-heading\">Product Technology &amp; Innovation<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Stent Platform:<\/strong> Expandable cobalt-chromium (CoCr) alloy coronary stent<\/li>\n\n\n\n<li><strong>Delivery System:<\/strong> Integrated balloon delivery system for precise deployment<\/li>\n\n\n\n<li><strong>Dual-Polymer Design:<\/strong><\/li>\n\n\n\n<li><strong>Base Layer:<\/strong> Non-erodible polymer for structural stability<\/li>\n\n\n\n<li><strong>Surface Layer:<\/strong> Biodegradable polymer for controlled drug release<\/li>\n\n\n\n<li><strong>Drug Elution:<\/strong> Optimized pharmacokinetic profile for sustained therapeutic effect<\/li>\n\n\n\n<li><strong>Manufacturing:<\/strong> Proprietary coating technology ensuring uniform drug distribution<\/li>\n<\/ul>\n\n\n\n<h2 id=\"h-market-opportunity-amp-commercial-strategy\" class=\"wp-block-heading\">Market Opportunity &amp; Commercial Strategy<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Colombian Market Size:<\/strong> Approximately 30,000 coronary stent procedures annually<\/li>\n\n\n\n<li><strong>Latin American Expansion:<\/strong> Colombia serves as gateway to broader regional markets (Brazil, Mexico, Argentina)<\/li>\n\n\n\n<li><strong>Competitive Landscape:<\/strong> Competes against established players (Medtronic, Abbott, Boston Scientific) with differentiated technology<\/li>\n\n\n\n<li><strong>Pricing Strategy:<\/strong> Expected 15-20% cost advantage vs. premium imported stents<\/li>\n\n\n\n<li><strong>Reimbursement Status:<\/strong> Working with Colombian healthcare system for inclusion in national formulary<\/li>\n<\/ul>\n\n\n\n<h2 id=\"h-strategic-significance-for-sino-medical-sciences\" class=\"wp-block-heading\">Strategic Significance for Sino Medical Sciences<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>International Diversification:<\/strong> Reduces reliance on domestic Chinese market (currently >80% of revenue)<\/li>\n\n\n\n<li><strong>Regulatory Milestone:<\/strong> First major Latin American approval demonstrates global quality standards compliance<\/li>\n\n\n\n<li><strong>Technology Validation:<\/strong> Dual-polymer platform recognition by stringent regulatory authority<\/li>\n\n\n\n<li><strong>Revenue Impact:<\/strong> Potential $15-25 million annual revenue contribution from Colombian market alone<\/li>\n\n\n\n<li><strong>Pipeline Catalyst:<\/strong> Success may accelerate approvals in other Latin American jurisdictions<\/li>\n<\/ul>\n\n\n\n<h2 id=\"h-product-differentiation-amp-clinical-advantages\" class=\"wp-block-heading\">Product Differentiation &amp; Clinical Advantages<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Reduced Restenosis Risk:<\/strong> Biodegradable polymer minimizes long-term inflammatory response<\/li>\n\n\n\n<li><strong>Enhanced Safety Profile:<\/strong> Non-erodible base layer provides mechanical stability during healing phase<\/li>\n\n\n\n<li><strong>Optimized Healing:<\/strong> Controlled drug release kinetics support endothelialization while preventing neointimal hyperplasia<\/li>\n\n\n\n<li><strong>Procedural Efficiency:<\/strong> Low-profile delivery system enables access to complex anatomies<\/li>\n\n\n\n<li><strong>Cost-Effectiveness:<\/strong> Superior clinical outcomes at competitive price point vs. imported alternatives<\/li>\n<\/ul>\n\n\n\n<h2 id=\"h-development-timeline-amp-next-steps\" class=\"wp-block-heading\">Development Timeline &amp; Next Steps<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Commercial Launch:<\/strong> Expected Q3 2026 following distributor partnerships and physician training<\/li>\n\n\n\n<li><strong>Market Access:<\/strong> Engaging with Colombian hospitals and cardiac centers for adoption<\/li>\n\n\n\n<li><strong>Regional Expansion:<\/strong> Regulatory submissions planned for Brazil (ANVISA) and Mexico (COFEPRIS) in H2 2026<\/li>\n\n\n\n<li><strong>Clinical Evidence:<\/strong> Real-world evidence generation program to support broader adoption<\/li>\n\n\n\n<li><strong>Product Portfolio:<\/strong> Potential introduction of additional stent platforms based on HT Supreme success<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Forward\u2011Looking Statements<\/strong><br>This brief contains forward-looking statements regarding regulatory approvals, commercial launches, and market expectations for the HT Supreme stent system. Actual results may differ due to market adoption rates, competitive dynamics, reimbursement decisions, and regulatory developments in other jurisdictions.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n\n\n\n<div data-wp-interactive=\"core\/file\" class=\"wp-block-file\"><object data-wp-bind--hidden=\"!state.hasPdfPreview\" hidden class=\"wp-block-file__embed\" data=\"https:\/\/flcube.com\/wp-content\/uploads\/2026\/06\/688108_20260606_4AHD.pdf\" type=\"application\/pdf\" style=\"width:100%;height:600px\" aria-label=\"Embed of 688108_20260606_4AHD.\"><\/object><a id=\"wp-block-file--media-050707cf-63b0-4d47-a566-e2ce9b54420d\" href=\"https:\/\/flcube.com\/wp-content\/uploads\/2026\/06\/688108_20260606_4AHD.pdf\">688108_20260606_4AHD<\/a><a href=\"https:\/\/flcube.com\/wp-content\/uploads\/2026\/06\/688108_20260606_4AHD.pdf\" class=\"wp-block-file__button wp-element-button\" download aria-describedby=\"wp-block-file--media-050707cf-63b0-4d47-a566-e2ce9b54420d\">Download<\/a><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Sino Medical Sciences Technology Inc. (SHA: 688108) announced it has received marketing approval from Colombia&#8217;s&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,22],"tags":[15,1054,298],"class_list":["post-67698","post","type-post","status-publish","format-standard","hentry","category-company","category-medical-device","tag-product-approvals","tag-sha-688108","tag-sino-medical-sciences-technology"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.5 (Yoast SEO v27.7) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Sino Medical Sciences Secures Colombian Approval for HT Supreme Drug-Eluting Stent \u2013 Advanced Dual-Polymer Technology Expands Latin American Presence - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Sino Medical Sciences Technology Inc. (SHA: 688108) announced it has received marketing approval from Colombia&#039;s Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA) for its HT Supreme drug-eluting stent system. The approval enables commercial use in symptomatic heart disease patients with primary coronary artery lesions, marking a significant expansion of the Chinese medical device manufacturer&#039;s presence in the Latin American cardiovascular market.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=67698\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Sino Medical Sciences Secures Colombian Approval for HT Supreme Drug-Eluting Stent \u2013 Advanced Dual-Polymer Technology Expands Latin American Presence\" \/>\n<meta property=\"og:description\" content=\"Sino Medical Sciences Technology Inc. (SHA: 688108) announced it has received marketing approval from Colombia&#039;s Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA) for its HT Supreme drug-eluting stent system. The approval enables commercial use in symptomatic heart disease patients with primary coronary artery lesions, marking a significant expansion of the Chinese medical device manufacturer&#039;s presence in the Latin American cardiovascular market.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=67698\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2026-06-08T14:03:06+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-06-08T14:03:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1894\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=67698#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=67698\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Sino Medical Sciences Secures Colombian Approval for HT Supreme Drug-Eluting Stent \u2013 Advanced Dual-Polymer Technology Expands Latin American Presence\",\"datePublished\":\"2026-06-08T14:03:06+00:00\",\"dateModified\":\"2026-06-08T14:03:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=67698\"},\"wordCount\":466,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"keywords\":[\"Product approvals\",\"SHA: 688108\",\"Sino Medical Sciences Technology\"],\"articleSection\":[\"Company\",\"Medical Device\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=67698#respond\"]}],\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=67698\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=67698\",\"name\":\"Sino Medical Sciences Secures Colombian Approval for HT Supreme Drug-Eluting Stent \u2013 Advanced Dual-Polymer Technology Expands Latin American Presence - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"datePublished\":\"2026-06-08T14:03:06+00:00\",\"dateModified\":\"2026-06-08T14:03:08+00:00\",\"description\":\"Sino Medical Sciences Technology Inc. (SHA: 688108) announced it has received marketing approval from Colombia's Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA) for its HT Supreme drug-eluting stent system. The approval enables commercial use in symptomatic heart disease patients with primary coronary artery lesions, marking a significant expansion of the Chinese medical device manufacturer's presence in the Latin American cardiovascular market.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=67698#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=67698\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=67698#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Sino Medical Sciences Secures Colombian Approval for HT Supreme Drug-Eluting Stent \u2013 Advanced Dual-Polymer Technology Expands Latin American Presence\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Sino Medical Sciences Secures Colombian Approval for HT Supreme Drug-Eluting Stent \u2013 Advanced Dual-Polymer Technology Expands Latin American Presence - Insight, China&#039;s Pharmaceutical Industry","description":"Sino Medical Sciences Technology Inc. (SHA: 688108) announced it has received marketing approval from Colombia's Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA) for its HT Supreme drug-eluting stent system. The approval enables commercial use in symptomatic heart disease patients with primary coronary artery lesions, marking a significant expansion of the Chinese medical device manufacturer's presence in the Latin American cardiovascular market.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=67698","og_locale":"en_US","og_type":"article","og_title":"Sino Medical Sciences Secures Colombian Approval for HT Supreme Drug-Eluting Stent \u2013 Advanced Dual-Polymer Technology Expands Latin American Presence","og_description":"Sino Medical Sciences Technology Inc. (SHA: 688108) announced it has received marketing approval from Colombia's Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA) for its HT Supreme drug-eluting stent system. The approval enables commercial use in symptomatic heart disease patients with primary coronary artery lesions, marking a significant expansion of the Chinese medical device manufacturer's presence in the Latin American cardiovascular market.","og_url":"https:\/\/flcube.com\/?p=67698","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2026-06-08T14:03:06+00:00","article_modified_time":"2026-06-08T14:03:08+00:00","og_image":[{"width":2560,"height":1894,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","type":"image\/jpeg"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=67698#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=67698"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Sino Medical Sciences Secures Colombian Approval for HT Supreme Drug-Eluting Stent \u2013 Advanced Dual-Polymer Technology Expands Latin American Presence","datePublished":"2026-06-08T14:03:06+00:00","dateModified":"2026-06-08T14:03:08+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=67698"},"wordCount":466,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"keywords":["Product approvals","SHA: 688108","Sino Medical Sciences Technology"],"articleSection":["Company","Medical Device"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=67698#respond"]}],"copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=67698","url":"https:\/\/flcube.com\/?p=67698","name":"Sino Medical Sciences Secures Colombian Approval for HT Supreme Drug-Eluting Stent \u2013 Advanced Dual-Polymer Technology Expands Latin American Presence - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"datePublished":"2026-06-08T14:03:06+00:00","dateModified":"2026-06-08T14:03:08+00:00","description":"Sino Medical Sciences Technology Inc. (SHA: 688108) announced it has received marketing approval from Colombia's Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA) for its HT Supreme drug-eluting stent system. The approval enables commercial use in symptomatic heart disease patients with primary coronary artery lesions, marking a significant expansion of the Chinese medical device manufacturer's presence in the Latin American cardiovascular market.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=67698#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=67698"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=67698#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Sino Medical Sciences Secures Colombian Approval for HT Supreme Drug-Eluting Stent \u2013 Advanced Dual-Polymer Technology Expands Latin American Presence"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/67698","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=67698"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/67698\/revisions"}],"predecessor-version":[{"id":67700,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/67698\/revisions\/67700"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=67698"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=67698"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=67698"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}